Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 86 M102 M82 M107 M157 M168 M 514 M Research & development 43 M44 M43 M46 M54 M56 M 199 M Operating income 249 M256 M204 M171 M195 M291 M 861 M Non-Operating Income, Total 5 M8 M2 M1 M-2 M-9 M -8 M Interest expense, net of interest capitalized ——5 M3 M7 M2 M 17 M Non-Operating Income, excl. Interest Expenses 00-5 M-3 M-7 M-2 M -17 M Unusual income/expense 5 M8 M2 M1 M-2 M-9 M -8 M Pretax income 233 M242 M182 M147 M132 M228 M 689 M Equity in earnings —————— — Taxes 41 M47 M45 M48 M20 M47 M 160 M Non-controlling/minority interest —————— — After tax other income/expense -1 M01 M3 M-7 M6 M 3 M Net income before discontinued operations 192 M195 M137 M99 M112 M181 M 529 M Discontinued operations —————— — Net income 192 M195 M137 M99 M112 M181 M 529 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 192 M195 M137 M99 M112 M181 M 529 M Basic earnings per share (Basic EPS) 2.262.321.631.211.352.18 6.37 Diluted earnings per share (Diluted EPS) 2.232.291.631.181.332.15 6.29 Average basic shares outstanding 85 M84 M84 M84 M83 M83 M — Diluted shares outstanding 86 M85 M84 M85 M84 M84 M — EBITDA 298 M263 M210 M187 M198 M303 M 898 M EBIT 226 M233 M178 M147 M110 M192 M 627 M Cost of revenue 388 M412 M364 M384 M1 B1.05 B 2.8 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 30 M30 M32 M40 M88 M111 M 271 M